L3VLUP
ProSign in

DGX · ELV in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

DGXELV
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • DGX
  • ELV
010203040202120222023202420252026
Holders and value by quarter
QuarterDGXELV
Q3 202018 holders, $1.0bn30 holders, $15.0bn
Q4 202021 holders, $1.1bn29 holders, $16.7bn
Q1 202119 holders, $1.2bn25 holders, $18.6bn
Q2 202114 holders, $975m30 holders, $19.4bn
Q3 202117 holders, $1.1bn26 holders, $18.5bn
Q4 202117 holders, $1.5bn29 holders, $23.3bn
Q1 202216 holders, $812m31 holders, $23.9bn
Q2 202216 holders, $813m32 holders, $23.3bn
Q3 202216 holders, $910m34 holders, $22.6bn
Q4 202213 holders, $1.1bn34 holders, $25.5bn
Q1 202317 holders, $989m39 holders, $22.5bn
Q2 202316 holders, $1.3bn38 holders, $20.6bn
Q3 202315 holders, $1.1bn34 holders, $19.8bn
Q4 202311 holders, $1.2bn36 holders, $20.3bn
Q1 202410 holders, $777m35 holders, $21.3bn
Q2 202413 holders, $1.2bn33 holders, $22.1bn
Q3 202411 holders, $1.7bn30 holders, $20.2bn
Q4 20249 holders, $1.6bn32 holders, $15.9bn
Q1 202510 holders, $1.8bn28 holders, $17.1bn
Q2 202510 holders, $2.4bn27 holders, $14.8bn
Q3 202513 holders, $2.5bn27 holders, $12.7bn
Q4 202510 holders, $1.5bn25 holders, $17.0bn
Q1 20269 holders, $1.6bn26 holders, $13.6bn
Q2 20267 holders, $1.6bn28 holders, $17.7bn
DGX

Quest Diagnostics Inc

Holders
13
Reported value
$2.5bn
Buyers
6
Sellers
7

Breadth -1 among 95 comparable managers.

Health care services and research
ELV

Elevance Health Inc Formerly

Holders
27
Reported value
$12.7bn
Buyers
18
Sellers
9

Breadth +9 among 95 comparable managers.

Health care services and researchManaged care

Who holds both, Q3 2025

Among the 34 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only DGX (7)

Balyasny Asset Management LLC, Caxton Associates LLP, Marshall Wace LLP, Maverick Capital Ltd, Neuberger Berman Group LLC, Verition Fund Management LLC, Woodline Partners LP

Only ELV (21)

Acadian Asset Management LLC, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, Baupost Group LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, D. E. Shaw & Co., Discovery Capital Management LLC, Dodge & Cox, Harris Associates LP, Janus Henderson Group Ltd, MFS Investment Management, Moore Capital Management LP, Quantbot Technologies LP, Ruane Cunniff & Goldfarb LP, Schonfeld Strategic Advisors LLC, Tudor Investment Corp, Two Sigma Investments LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →